Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach
The inclusion of productivity costs can affect the outcome of cost-effectiveness analyses. We estimated the value of cancer premature mortality productivity costs for Europe in 2020 using the Human Capital Approach (HCA) and compared these to the Friction Cost Approach (FCA). Cancer mortality data w...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-05-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/29/5/287 |
| _version_ | 1797500536668291072 |
|---|---|
| author | Paul Hanly Marta Ortega-Ortega Isabelle Soerjomataram |
| author_facet | Paul Hanly Marta Ortega-Ortega Isabelle Soerjomataram |
| author_sort | Paul Hanly |
| collection | DOAJ |
| description | The inclusion of productivity costs can affect the outcome of cost-effectiveness analyses. We estimated the value of cancer premature mortality productivity costs for Europe in 2020 using the Human Capital Approach (HCA) and compared these to the Friction Cost Approach (FCA). Cancer mortality data were obtained from GLOBOCAN 2020 by sex and five-year age groups. Twenty-three cancer sites for 31 European countries were included. The HCA and the FCA were valued using average annual gross wages by sex and age group and applied to Years of Potential Productive Life Lost. 2020 friction periods were calculated and all costs were in 2020 euros. Estimated cancer premature mortality costs for Europe in 2020 were EUR 54.0 billion (HCA) and EUR 1.57 billion (FCA). The HCA/FCA cost ratio for Europe was 34.4, but considerable variation arose across countries (highest in Ireland: 64.5 v lowest in Czech Republic: 11.1). Both the HCA and the FCA ranked lung, breast and colorectal as the top three most costly cancers in Europe, but cost per death altered rankings substantially. Significant cost differences were observed following sensitivity analysis. Our study provides a unique perspective of the difference between HCA and FCA estimates of productivity costs by cancer site and country in Europe. |
| first_indexed | 2024-03-10T03:04:17Z |
| format | Article |
| id | doaj.art-d7151d474c004b97b39e15e9c1b4f98b |
| institution | Directory Open Access Journal |
| issn | 1198-0052 1718-7729 |
| language | English |
| last_indexed | 2024-03-10T03:04:17Z |
| publishDate | 2022-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Current Oncology |
| spelling | doaj.art-d7151d474c004b97b39e15e9c1b4f98b2023-11-23T10:37:20ZengMDPI AGCurrent Oncology1198-00521718-77292022-05-012953552356410.3390/curroncol29050287Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost ApproachPaul Hanly0Marta Ortega-Ortega1Isabelle Soerjomataram2School of Business, National College of Ireland, Dublin 1, IrelandDepartment of Applied Economics, Public Economics and Political Economy, Faculty of Economics and Business, Complutense University of Madrid, Campus de Somosaguas, 28223 Madrid, SpainInternational Agency for Research on Cancer, 69372 Lyon, FranceThe inclusion of productivity costs can affect the outcome of cost-effectiveness analyses. We estimated the value of cancer premature mortality productivity costs for Europe in 2020 using the Human Capital Approach (HCA) and compared these to the Friction Cost Approach (FCA). Cancer mortality data were obtained from GLOBOCAN 2020 by sex and five-year age groups. Twenty-three cancer sites for 31 European countries were included. The HCA and the FCA were valued using average annual gross wages by sex and age group and applied to Years of Potential Productive Life Lost. 2020 friction periods were calculated and all costs were in 2020 euros. Estimated cancer premature mortality costs for Europe in 2020 were EUR 54.0 billion (HCA) and EUR 1.57 billion (FCA). The HCA/FCA cost ratio for Europe was 34.4, but considerable variation arose across countries (highest in Ireland: 64.5 v lowest in Czech Republic: 11.1). Both the HCA and the FCA ranked lung, breast and colorectal as the top three most costly cancers in Europe, but cost per death altered rankings substantially. Significant cost differences were observed following sensitivity analysis. Our study provides a unique perspective of the difference between HCA and FCA estimates of productivity costs by cancer site and country in Europe.https://www.mdpi.com/1718-7729/29/5/287societal perspectivecancerproductivity costshuman capital approachfriction cost approacheconomic evaluation |
| spellingShingle | Paul Hanly Marta Ortega-Ortega Isabelle Soerjomataram Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach Current Oncology societal perspective cancer productivity costs human capital approach friction cost approach economic evaluation |
| title | Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach |
| title_full | Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach |
| title_fullStr | Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach |
| title_full_unstemmed | Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach |
| title_short | Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach |
| title_sort | cancer premature mortality costs in europe in 2020 a comparison of the human capital approach and the friction cost approach |
| topic | societal perspective cancer productivity costs human capital approach friction cost approach economic evaluation |
| url | https://www.mdpi.com/1718-7729/29/5/287 |
| work_keys_str_mv | AT paulhanly cancerprematuremortalitycostsineuropein2020acomparisonofthehumancapitalapproachandthefrictioncostapproach AT martaortegaortega cancerprematuremortalitycostsineuropein2020acomparisonofthehumancapitalapproachandthefrictioncostapproach AT isabellesoerjomataram cancerprematuremortalitycostsineuropein2020acomparisonofthehumancapitalapproachandthefrictioncostapproach |